Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
<h4>Background</h4>Published pharmaceutical industry-sponsored trials are more likely than non-industry-sponsored trials to report results and conclusions that favor drug over placebo. Little is known about potential biases in drug-drug comparisons. This study examined associations betwe...
Main Authors: | Lisa Bero, Fieke Oostvogel, Peter Bacchetti, Kirby Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-06-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.0040184 |
Similar Items
-
Association of trial registration with the results and conclusions of published trials of new oncology drugs
by: Bero Lisa, et al.
Published: (2009-12-01) -
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
by: Kristin Rising, et al.
Published: (2008-11-01) -
Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation.
by: Kristin Rising, et al.
Published: (2009-01-01) -
Why publishing everything is more effective than selective publishing of statistically significant results.
by: Marcel A L M van Assen, et al.
Published: (2014-01-01) -
Why are some plant genera more invasive than others?
by: John Paul Schmidt, et al.
Published: (2011-01-01)